Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Judith Balmañà

机构:Hebron University, Vall d'Hebron Institut de Recerca, Tumour Institute of Tuscany, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology · ORCID:0000-0002-0762-6415

发表论文 618 篇 · 总被引 19802 次 · h-index 67

代表论文

  • Bridging the gap: integrating hereditary cancer into precision oncology (2026 · European Journal of Human Genetics · 被引 1)
  • Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework (2026 · European Journal of Human Genetics · 被引 1)
  • Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success (2026 · ESMO Open)
  • Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers (2026 · JAMA Network Open)
  • Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer (2026 · ESMO Open)
  • Barriers and Enablers Influencing Clinical Recommendations and Referrals for Rare Tumour Risk Syndromes: A Mixed-Methods Study Across Six European Countries (2026 · Research Square)